Table 1: General characteristics of the study population.

 

Total Subjects

rtCGM

isCGM

p-value (2-tailed)*

N

117

78

39

 

Male (n, %)

57 (48.7%)

41 (52.6%)

16 (41%)

0.24

Age at diagnosis (years)

6.8 (3.4)

5.9 (3.0)

8.4 (3.5)

< 0.001

Age at last visit (years)

11.9 (3.4)

11.0 (3.6)

13.7 (1.9)

< 0.001

Duration of diabetes (years)

5.1 (3.7)

5.1 (3.6)

5.3 (3.9)

0.76

Weight SDS

0.67 (0.9)

0.59 (0.9)

0.82 (1.1)

0.28

Height SDS

0.49 (0.9)

0.43 (0.9)

0.62 (1.0)

0.33

BMI SDS

0.55 (1.0)

0.49 (1.0)

0.67 (1.0)

0.39

% CGM Use (3 months)

92.5 (7.9)

94.5 (6.3)

88.3 (9.0)

< 0.001

HbA1c (mmol/mol)

57.2 (11.7)

54.7 (10.8)

62.1 (12.1)

0.002

HbA1C (%)

7.38 (1.1%)

7.16 (1.0%)

7.83 (1.1%)

0.002

3-month GMI (mmol/mol)

59.0 (9.3)

57.2 (8.5)

62.7 (9.9)

0.004

3-month GMI (%)

7.55 (0.8%)

7.38 (0.8%)

7.89 (0.9%)

0.004

Data are n (%) or mean (SD), *Independent T-test, BMI: Body Mass Index; SDS: Standard Deviation Score; CGM: Continuous Glucose Monitoring; rtCGM: real time CGM; isCGM: intermittently scanned CGM; HbA1C: Haemoglobin A1C; GMI: Glucose Management Index